Perfusion MDCT Enables Early Detection of Therapeutic Response to Antiangiogenic Therapy-Reference-Cited by-同舟云学术

Perfusion MDCT Enables Early Detection of Therapeutic Response to Antiangiogenic Therapy

Published:2008-07 Issue:1 Volume:191 Page:133-139
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Sabir Adeel,Schor-Bardach Rachel,Wilcox Carol J.,Rahmanuddin Syed,Atkins Michael B.,Kruskal Jonathan B.,Signoretti Sabina,Raptopoulos Vassilios D.,Goldberg S. Nahum

Publisher

American Roentgen Ray Society

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

2. Flaherty KT. Sorafenib in renal cell carcinoma.Clin Cancer Res2007; 13(2 Pt 2): 747S–752S

3. Hutson TE, Sonpavde G, Galsky MD. Targeting growth factor and antiangiogenic pathways in clear-cell renal cell carcinoma: rationale and ongoing trials.Clin Genitourin Cancer2006; 5[suppl 1]:S31 –S39

4. Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma

5. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline parameters of spectral CT could predict tumor response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients;Journal of Interventional Medicine;2024-01

2. Differential dependency of human glioblastoma cells on vascular endothelial growth factor‑A signaling via neuropilin‑1;International Journal of Oncology;2022-08-29

3. Current Imaging Evaluation of Tumor Response to Advanced Medical Treatment in Metastatic Renal-Cell Carcinoma: Clinical Implications;Applied Sciences;2021-07-28

4. Dynamic Computed Tomography Perfusion Imaging: Complementary Diagnostic Tool in Hepatocellular Carcinoma Assessment From Diagnosis to Treatment Follow-up;Academic Radiology;2019-12

5. The beginning of the end for conventional RECIST — novel therapies require novel imaging approaches;Nature Reviews Clinical Oncology;2019-02-04